Towa’s New Overseas Business Boosted By COVID-19 Demand
Acquired Pensa Investment Assets
Japan’s Towa Pharmaceutical endured a mixed financial first quarter, seeing the April round of Japanese National Health Insurance pricing measures bite into domestic sales while its new overseas business thrived as COVID-19 pushed up demand.
